Systemic antifungal treatment of children with terbinafine

Dermatology

Volumn 195, Issue 2, 1997, Pages 134-136

  Bruckbauer, H R ^a   Hofmann, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Microsporum canis; Terbinafine; Tinea capitis; Trichophyton mentagrophytes; Trichophyton violaceum

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIFUNGAL AGENT; TERBINAFINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MICROSPORUM CANIS; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCALP; SCHOOL CHILD; TINEA CAPITIS; TINEA CORPORIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON VIOLACEUM; URTICARIA;

EID: 0030839249     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245715     Document Type: Article

References (15)

1. Haroon TS, Hussain I. Mahmood A, Nagi AH. Ahmad I Zahid M: An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992;126(suppl39):47-50.
2. Petranyi G. Meingassner JG, Mieth H: Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987:31:1365-1368.
3. Clayton YM: Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130(suppl 43):7-8.
4. Degreef JH. De Doncker PRG: Current therapy of dermatophytosis. J Am Acad Dermatol 1994:31 (suppl):25-30.
5. Finlay AY: Global overview of Lamisil. Br J Dermatol 1994:130(suppl 43): 1-3.
6. Gupta AK. Sauder DN. Shear NH: Antifungal agents: An overview. Part II. J Am Acad Dermatol 1994:30:911-933.
7. Brautigam M: Produktmonographie Lamisil. ed 2, rev. NUrnberg, Sandoz AG. 1995.
8. Jones TC: Overview of the use of terbinafine (Lamisil) in children. BrJ Dermatol 1995:132: 683-689.
9. Nejjam F. Zagula M. Cabiac MD, Guessous N. Humbert H, Lakhdar H: Pilot study of terbinafine in children suffering from tinea capitis: Evaluation of efficacy, safety and pharmacokinetics. BrJ Dermatol 1995:132:98-105.
10. Desgarennes CP. Godoy MR. Palencia AB: Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans. J Am Acad Dermatol 1996;35:l14-116.
11. Baudraz-Rossclet F, Monod M, Jaccoud S. Frenk E: Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species (letter). Br J Dermatol 1996:135:1011-1012.
12. Lopez-Gomez S. Del Palacio A. Van Cutsem J. Soledad-Cuetara M. Iglesias L. Rodriguez-Noricga A: Itraconazole versus griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children. Int J Dermatol 1994:33:743-747.
13. Todd P, Halpern S. Munro DD: Oral terbinafine and erythema multiforme. Clin Exp Dermatol 1995:20:247-248.
14. Wach F. Stolz W. Hein R. Landthaler M: Severe erythema anulare centrifugum-likc psoriatic drug eruption induced by terbinafine (letter). Arch Dermatol 1995; 131:960-961.
15. Carstens J. Wendelboe P, Sogaard H, Thestrup-Pedersen K: Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol (Stockh) 1994:74:391-392.